Pfizer Inc. (NYSE:PFE) Is To Maintain Repurchase Stock- Eli Lilly and Company (NYSE:LLY), Shire plc (NASDAQ:SHPG)

Pfizer Inc. (NYSE:PFE) declared that it notified Pain Therapeutics Inc. that it is ending its contract to develop and commercialize an investigational extensive-release version of oxycodone. The pharmaceutical giant stated that it would return all rights to the investigational drug, called Remoxy, to Pain Therapeutics, Inc. (NASDAQ:PTIE) and that the two firms will persevere to work together during a six-month transition period. U.S. drugmaker Pfizer is to maintain repurchase stock, with the board approving a new $11B share buyback plan, deflating anticipations that it will make a new bid for AstraZeneca. Pfizer Inc. (NYSE:PFE) showed itself as moving stock, plunged -0.27% to close at $29.03. Its total outstanding shares are 6340.86 million shares and floated shares were 6337.76 million with the market capitalization of 184.1 Billion.Eli Lilly and Company (NYSE:LLY) released that the following statement in reaction to a judge's ruling that the punitive damages awarded in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No. 6:12-cv-00064 be reduced. The adjudicator in the Louisiana multidistrict litigation examination cut the punitive damages from $3 billion for Lilly and $6B for Takeda to $9.2M for Lilly and $27.6M for Takeda. Shares of Eli Lilly and Company (NYSE:LLY) trading start with a price of $66.02 and throughout the trading session hit its highest level of $66.62 and at the time when day-trade ended the stock finally raised 0.23% to closed at $66.20.Shire plc (NASDAQ:SHPG) reported that unaudited results for the three months to September 30, 2014. Shire's Chairman, Susan Kilsby stated that Shire is well-positioned for prospect growth as they implement their plan to double product sales to $10B by 2020. He is confident that Shire, as an independent company, will deliver long-term value to thier shareholders and improved outcomes for patients. Shire plc (NASDAQ:SHPG) has 196.99 million outstanding shares with market capitalization of 38.364 Billion. The company stock closed at $195.87 by moving up 0.71% in last trading day. As the returns are concern, return on equity was recorded 20.60% and firm increased its return on investment 27.10% while its return on asset stayed at 11.30%.